BlackRock Fund Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

BlackRock Fund Advisors’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$159K	Buy	723 +15	+2%	+$3.01K	﹤0.01%	3488
2016 Q3	$170K	Sell	708 -4	-0.6%	-$831	﹤0.01%	3498
2016 Q2	$139K	Buy	712 +141	+25%	+$65K	﹤0.01%	3571
2016 Q1	$245K	Sell	571 -46	-7%	-$16.4K	﹤0.01%	3397
2015 Q4	$233K	Buy	617 +17	+3%	+$5.33K	﹤0.01%	3473
2015 Q3	$163K	Sell	600 -16	-3%	-$4.46K	﹤0.01%	3559
2015 Q2	$181K	Buy	616 +75	+14%	+$22.7K	﹤0.01%	3561
2015 Q1	$149K	Buy	+541	New	+$234K	﹤0.01%	3551

Other funds holding DMK

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SGS

Sterling Global Strategies Carlsbad, California $18M AUM 11.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Fund Advisors's DMK Position: Q4 2016 in Review

BlackRock Fund Advisors increased its DMK Pharmaceuticals Corporation Common Stock (DMK) stake by 2.1% in Q4 2016, buying an estimated $3.01K and bringing the position to 723 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #3488.

BlackRock Fund Advisors first reported a position in DMK in Q1 2015 and has held it in 8 quarters since. The position peaked at $245K in Q1 2016. 35 funds tracked by Wall St. Rank hold DMK as of Q4 2016.

BlackRock Fund Advisors held 723 shares of DMK Pharmaceuticals Corporation Common Stock worth $159K as of Q4 2016.
BlackRock Fund Advisors bought 15 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2016, an estimated $3.01K.
DMK Pharmaceuticals Corporation Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3488 holding.
BlackRock Fund Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2015 and has held it in 8 quarters since.
BlackRock Fund Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $245K in Q1 2016.
35 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.